Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
Lancet 2002
& Nishimoto, H
This proprietary formulation containsnanonized, liposomal phosphatidylcholine (PC)a primary lipid component of cell membranes
Additionally, in the CGI-I scores there was a significant improvement in social interaction, aberrant behavior and verbal communication compared to placebo
US$ 22.78
/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788238.jpeg)
US$ 22.97
US$ 25.26
.png)
US$ 24.69
